Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930184-98-000006
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
16
Period of Report
1997-12-31
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 SEC FORM 10K 10-K 272281
2 CERTIFICATE OF DESIGNATIONS EX-3.5 29058
3 MATERIAL CONTRACT EX-10.22 232409
4 CREDIT AGREEMENT EX-10.23 98798
5 SECOND AMENDMENT TO CREDIT AGREEMENT EX-10.24 5700
6 SUBSIDIARIES OF THE REGISTRANT EX-21 3271
7 CONSENT OF INDEPENDENT ACCOUNTANTS EX-23 912
8 FINANCIAL DATA SCHEDULE EX-27.YEAR1997 2371
9 FINANCIAL DATA SCHEDULE EX-27.YEAR1996 2533
10 FINANCIAL DATA SCHEDULE EX-27.YEAR1995 2356
11 FINANCIAL DATA SCHEDULE EX-27.1STQTR1997 2384
12 FINANCIAL DATA SCHEDULE EX-27.2NDQTR1997 3308
13 FDS EX-27.3RDQTR1997 3331
14 FINANCIAL DATA SCHEDULE EX-27.1QTR1996 2390
15 FINANCIAL DATA SCHEDULE EX-27.2NDQTR1996 3198
16 FINANCIAL DATA SCHEDULE EX-27.3QTR1996 3203
  Complete submission text file 0000930184-98-000006.txt   670594
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7146683102
ICN PHARMACEUTICALS INC (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-11397 | Film No.: 98582596
SIC: 2834 Pharmaceutical Preparations